𝔖 Bobbio Scriptorium
✦   LIBER   ✦

PO-53 Phase II study of low molecular weight heparin (LMWH) in combination with immunotherapy in metastatic renal cell carcinoma patients

✍ Scribed by I. Tsimafeyeu; A. Madzhuga; L. Demidov; O. Somonova; A. Yelizarova

Book ID
117257888
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
51 KB
Volume
120
Category
Article
ISSN
0049-3848

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Granulocyte-macrophage–colony stimulatin
Granulocyte-macrophage–colony stimulating factor in combination immunotherapy for patients with metastatic renal cell carcinoma : Results of two Phase II clinical trials
✍ Christopher W. Ryan; Nicholas J. Vogelzang; Mary C. Dumas; Timothy Kuzel; Walter πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 94 KB πŸ‘ 2 views

The aim of this study was to determine the response rates and toxicity of two regimens containing granulocyte-macrophage-colony stimulating factor (GM-CSF) in combination with interleukin-2 (IL-2) in the treatment of patients with metastatic renal cell carcinoma. ## METHODS. Therapy given in the f